![Muin J. Khoury on X: "Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+. Muin J. Khoury on X: "Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+.](https://pbs.twimg.com/media/FBg19vmXsAUnJ3w.png:large)
Muin J. Khoury on X: "Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+.
![Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2016/1015/od1-t1.gif)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP
![PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0d1a9da91bb2852125f3fe77a8eb24002b62415/6-Figure1-1.png)
PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar
![Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/87/5/300/F1.large.jpg)
Aspirin for primary prevention of atherosclerotic cardiovascular events | Cleveland Clinic Journal of Medicine
![Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b8e58181-8c10-4d46-a114-99ddf25bf6ce/atvbaha.122.318020.fig06.jpg)
Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology
![Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer. | Semantic Scholar Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3d5a1cd4f360c0208e3832b310aa9207a3dc9175/5-Table2-1.png)
Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer. | Semantic Scholar
![JAMA on X: "Low-Dose Aspirin For Primary Prevention of Cardiovascular Disease - Share The Decision! https://t.co/r4gxUeFxRL https://t.co/BudUieIBjS" / X JAMA on X: "Low-Dose Aspirin For Primary Prevention of Cardiovascular Disease - Share The Decision! https://t.co/r4gxUeFxRL https://t.co/BudUieIBjS" / X](https://pbs.twimg.com/media/DIhdzmyXgAA1lAp.jpg)